News Home

CymaBay Therapeutics Inc (CBAY) Stock: Is It a Good Pick?

Friday, February 12, 2021 03:22 PM | InvestorsObserver Analysts
CymaBay Therapeutics Inc (CBAY) Stock: Is It a Good Pick?

CymaBay Therapeutics Inc (CBAY) stock is higher by 288.00% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CBAY stock a score of 66 out of a possible 100.

That rank is influenced by a fundamental score of 95. In addition to the average rating from Wall Street analysts, CBAY stock has a mean target price of 12.909. This means analysts expect the stock to increase 121.80% over the next 12 months. CBAY's rank also includes a short-term technical score of 92. The long-term technical score for CBAY is 10.

Overall Score - 66
CBAY has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on CBAY!

What's Happening with CBAY Stock Today

CymaBay Therapeutics Inc (CBAY) stock has fallen -3.41% while the S&P 500 is higher by 0.12% as of 3:18 PM on Friday, Feb 12. CBAY is down -$0.20 from the previous closing price of $6.02 on volume of 1,498,974 shares. Over the past year the S&P 500 has gained 16.21% while CBAY is higher by 288.00%. CBAY lost -$0.94 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on CymaBay Therapeutics Inc (CBAY) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App